Click image to inspect pack details
Respiratory Range Marketed by Aerochem Neutron

Bilaero-M

Formulation Code AC-404
Commercial Status Active Product Information Available

Product Overview & Formulation Profile

Bilaero-M is listed as containing Bilastine 20 mg, a second-generation antihistamine. Bilastine selectively blocks peripheral histamine H1 receptors, helping address histamine-related symptoms in allergic conditions such as allergic rhinitis. The product is presented as an oral tablet in the Respiratory Range. Use should be guided by clinical assessment and the applicable product label; healthcare professionals should consider patient-specific factors when selecting treatment.

Composition & Formulation Details

·       Contains Bilastine 20mg + Montelukast 10mg

·       Bilastine — non-sedating second-generation H1-antihistamine

·       Montelukast — leukotriene receptor antagonist that blocks cysteinyl leukotrienes involved in airway inflammation and bronchoconstriction

·       Presented as tablets

·       Prescription-only medicine

·       Allergic rhinitis

·       Sneezing, runny or blocked nose and itchy, watery eyes

·       Allergic rhinitis with asthma

·       Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination

Safety

·       Contraindicated in patients with known hypersensitivity to any component.

·       Should be taken away from food and fruit juice per label; caution with P-gp interactions in renal impairment.

·       Montelukast carries a regulatory warning for neuropsychiatric events (including sleep disturbance, depression and suicidal thoughts); patients should report mood or behaviour changes.

·       Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.

Clinical Rationale: The mechanisms and labelled uses of montelukast described here follow the US prescribing information (DailyMed). Evidence summary for Bilastine: reference verification pending. Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.

Professional Product Enquiries

Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.

Product Information

Review verified active composition, strength, dosage form, and packaging details on this page.

View Specifications

Healthcare Professional Enquiry

Request formulation literature, technical specifications, or product communication from our commercial team.

Submit Product Enquiry

Commercial Supply Enquiry

Connect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.

Commercial Enquiry

Professional Product Information

This product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.

Product Enquiry

Request Formulation Details

Request information about Bilaero-M for professional use.

Please enter the numeric sum to verify you are a human visitor.
Therapeutic Alternatives

Related Formulations

NILLE COLD Formulation
Respiratory Range

NILLE COLD

View Formulation
TOSOUT SM Formulation
Respiratory Range

TOSOUT SM

View Formulation
TOSOUT LC Formulation
Respiratory Range

TOSOUT LC

View Formulation
TOSOUT D Formulation
Respiratory Range

TOSOUT D

View Formulation
Product Information

Need specifications for this formulation?

Request verified product information for professional use, or send a separate business enquiry for manufacturing or partnership discussions.

WhatsApp: +91 9512047000